Focus on QA results in better informed consent

June 2011
Clinical Trials Administrator;Jun2011, Vol. 9 Issue 6, p63
The article discusses a quality assurance (QA) process implemented at the Vanderbilt University in Nashville, Tennessee to improve how research costs were explained to the participants in informed consent (IC) documents and to promote consistency across study documents. Key points of the QA process are outlined by the members of the university's human research protection program Barbara Gibson and LuEllen Davie.


Related Articles

  • CNE/CME QUESTIONS.  // Clinical Trials Administrator;Jun2011, Vol. 9 Issue 6, p72 

    A quiz concerning several topics discussed within the articles published in the June 2011 issue of "Clinical Trials Administrator" is presented.

  • Communications expert: speak no 'medicalese'  // Clinical Trials Administrator;Jun2011, Vol. 9 Issue 6, p65 

    The article offers an overview of a training program called PRISM (Program for Readability in Science and Medicine) developed by Jessica R. Ridpath, a research communications coordinator at Group Health Research Institute in Seattle, Washington, to help research investigators replace medical...

  • Audit toolbag puts focus on improvement.  // IRB Advisor;Mar2012, Vol. 12 Issue 3, p34 

    The article discusses an audit program used by Dana-Farber/Harvard Cancer Center (DF/HCC) to find areas in human subject's protection that need improvement. It mentions that the quality assurance (QA) auditing team has added two new review types in the program namely, targeted audits and risk...

  • IC experts advocate improvements to process.  // IRB Advisor;Dec2011, Vol. 11 Issue 12, p126 

    No abstract available.

  • Audits show researcher IC errors occur often.  // Clinical Trials Administrator;Aug2011, Vol. 9 Issue 8, p92 

    The article discusses the informed consent (IC) errors made by clinical trial sites with their prospective study participants and suggests ways to minimize them by developing a training series that focuses on IC for research staff. It suggests that they understand what auditors at research sites...

  • percepção dos doentes incluídos em ensaios clínicos relativamente ao processo de consentimento informado. Rodrigues Francisco, Maria de Fátima // Onco.news;mar-jun2012, Issue 20, p41 

    Clinical trials are the source for the development of new treatment strategies. Informed consent is an ethical safeguard for clinical trials candidates, in that it recognizes the autonomy to make decisions and the right to adequate information. However you must ensure that the information...

  • Compliance specialist finds these common informed consent errors.  // Clinical Trials Administrator;Aug2011, Vol. 9 Issue 8, p93 

    The article lists the informed consent errors found by a compliance specialist.

  • Consent forms for clinical trials are too aggressive. Wassersug, Richard J. // BMJ: British Medical Journal;8/17/2013, Vol. 347 Issue 7921, p23 

    The author focuses on the aspects of the languages used in informed consent forms in clinical trials. He mentions that the form should be in clear, plain English that could be understood by someone without a university degree. He further mentions that the unfriendly text from consent forms...

  • Evaluation of factors that motivate participants to consent for non-therapeutic trials in India. Doshi, Maulik Sumantbhai; Kulkarni, Shaunak P.; Ghia, Canna J.; Gogtay, Nithya J.; Thatte, Urmila Mukund // Journal of Medical Ethics;Jun2013, Vol. 39 Issue 6, p391 

    Background and rationale Several factors that motivate individuals to participate in non-therapeutic studies have been identified. This study was conducted as limited data is available regarding these motivations from developing countries. Methods This was a single-centre study conducted over 4...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics